Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) was the target of unusually large options trading on Thursday. Traders bought 17,442 call options on the company. This represents an increase of 97% compared to the typical daily volume of 8,842 call options.
Wall Street Analyst Weigh In
A number of research firms have weighed in on ISRG. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. HSBC boosted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the stock a "buy" rating in a report on Thursday. Leerink Partners boosted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an "outperform" rating in a report on Wednesday. Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating on the stock in a report on Tuesday, October 7th. Finally, Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $604.50.
Check Out Our Latest Analysis on Intuitive Surgical
Insider Activity at Intuitive Surgical
In related news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last three months. Company insiders own 0.70% of the company's stock.
Institutional Investors Weigh In On Intuitive Surgical
Several hedge funds have recently bought and sold shares of the company. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 40 shares during the period. Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter valued at approximately $26,000. Kilter Group LLC bought a new position in Intuitive Surgical in the second quarter valued at approximately $27,000. Finally, LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Price Performance
ISRG stock traded up $18.58 during trading hours on Thursday, reaching $545.61. 2,123,093 shares of the stock were exchanged, compared to its average volume of 2,115,816. The firm's 50-day moving average is $455.28 and its 200-day moving average is $495.80. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market cap of $195.59 billion, a price-to-earnings ratio of 72.02, a PEG ratio of 4.86 and a beta of 1.61.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.03%. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the business posted $1.84 EPS. The company's quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities research analysts forecast that Intuitive Surgical will post 6.43 earnings per share for the current year.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
